Take­da auc­tions off a $670M port­fo­lio of drugs and man­u­fac­tur­ing ops, get­ting clos­er to its $10B goal

Take­da is $670 mil­lion clos­er to its goal of sell­ing off $10 bil­lion in as­sets to help pay for the Shire buy­out.

The phar­ma gi­ant re­port­ed Fri­day that it has sold off a port­fo­lio of drugs and a pair of Eu­ro­pean man­u­fac­tur­ing sites to Den­mark’s Ori­farm Group. The lat­est in a string of auc­tions, capped by the $5.3 bil­lion sale of Xi­idra to No­var­tis, Take­da has been sys­tem­at­i­cal­ly auc­tion­ing off bits of the com­pa­ny to pay down debt built in the ac­qui­si­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER